Author:
Anwuri Victoria V.,Hall Lannis E.,Mathews Katherine,Springer Brian C.,Tappenden Jennifer R.,Farria Dione M.,Jackson Sherrill,Goodman Melody S.,Eberlein Timothy J.,Colditz Graham A.
Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. Freedman LS, Simon R, Foulkes MA, et al (1995) Inclusion of women and minorities in clinical trials and the NIH revitalization act of 1993—the perspective of NIH clinical trials. Control Clin Trials 16:277–285. Discussion 86-9, 93-309
2. Hohmann AA, Parron DL (1996) How the new NIH guidelines on inclusion of women and minorities apply: efficacy trials, effectiveness trials, and validity. J Consult Clin Psychol 64:851–855
3. (June 10, 1993) NIH Revitalization Act of 1993
4. (October 9, 2001) Amendment: NIH Policy and Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research, October 2001
5. Christian MC, Trimble EL (2003) Increasing participation of physicians and patients from underrepresented racial and ethnic groups in National Cancer Institute-sponsored clinical trials. Cancer Epidemiol Biomarkers Prev 12:S277–S283
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献